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The application of our recently acquired wealth of 
knowledge on endoori•e physiology to the problems of 
the menstrual cycle involves muoh "sifting of the chaff 
in seeking the grain". Though we have made great strides 
forward in recent years in the field of endocrinology, 
many gape still remain in our concepts. The whole mech-
anism of endocrine inter-play as we interpet it today is 
liable to change within a short time for several reasons. 
One of the outstanding weaknesses of our present concep-
tion of the endocrines is tha .. t only a fe•;v of the relation-
ships are known faote. The greater port ion are in real-
ity aesumpt ions based on clinical experience, a method 
of investigation prone to fallacy because of the varia-
bility of factors whcih are difficru.lt or impoeeibe to 
control in the human being. One real value oY this 
method, though, is that the work is on the human and by 
the time the work is completed·, there is no need to 
transfer findings from one species to another. Another 
weakness lies in the fact that controlled experiments 
are for the most part on animals. The bldnd transfer-
ence of animal findings to h1Jman phys ic:Dogy is a common 
fault of "laboratory technicians" and cres,tes mu ch fal-
"181042 
-2-
1acious •knowledge•. Though it is true that broad gen-
eralizations usually may be applied from speoiee to 
epeciee, isolated fact tends to be species specific. 
As e medical subject, we will of course stick to hu-
man findings aa closely as possible in this paper. 
It is the aim of this paper to attempt to clarify 
as much as possible the present status of the endo-
crines in relation to the menstrual cycle and to ab-
normalities of this cycle from etiological, diagnostic 
and therapeutic standpoints, emphasizing the first and 
last more than the diagnostic angle. 
The history of endocrinology is a comparatively 
recent one. Though the ancients back as far as Hippoc;;,.o 
rates postulated the humoral theory of physiology and 
the suggestions of ferments in the body are found in 
the writings of Sylviue, Willis, and others in the 
seventeenth century, it was not until the.nineteenth 
century and more particula.rly the last twenty-five 
years of that period that we can list much in the way 
of true endocrine knowledge or resea.rch. Berthold, 
Bernard and Brown-Sequard are probably the original 
founders of modern endocrinology. It was Brown-Sequard, 
who in 1888 created a great interest and furor not only 
in the medical profession but among the laity as well 







of extracts of animal testes. The biggest contributions 
to our knowledge of the endocrine• ha.a been from the ex-
perimental work completed •!nee.the turn of the century. 
Until more recently, many of the profession were very 
skeptical of the endocrines and their complexity. The 
recent past has seen some remarkallle work so that now 
the glands have many converts. It would appear that the 
' waive of enthuei8.lllll ie in its aacendenay at this time. 
It is necessary to thoroughly understand the basic 
no1rmal physiology of these structures before we can 
c~early evaluate the pathological entities. We must 
tllerefore diacuas the present conception of the bormones 
ofi menstruation and their inter-play before we attack 
t~e problem of anomalies of this cycle. 
Since the ovary ia the principal endocrine of the 
t•l• that distinguishes her from the male, it wi~l 
be our first concern. The ovary has two main functions·; 
t1he produoti on of ova and its endocrine activity. Both 
of theee actions, though racially impGrtant, are not 
eaeential to the life of the individual in contrast to 
m~y of the other glands of internal secretion such as 
the hypophysis, the adrenals, the pancrea~ and others. 
P1'ofound metabolic dieturba.noes follow removal of the 
t~roid, the parathyroids, the pituita.ry and other 




produces much less striking effects on body functions. 
Both of the ovarian functions, however,, are intimately 
a part of the normally balanced endocrine system. 
The ovary produces two types of eex hormones, the 
estrogenic hormones and the corpus luteum. hormone. The 
estrogenic substances are three in number. The name• 
which are recommended by the Council of 'harmacy and 
Chemistry of the American Medical Association are: 
1. Eatradiol or dihydrothee1in. This is most probably 
the hormone that is actually evolved by the follicle. 
(MacCorquodale, Thayer and Doisy, 1~35) 
a. Eatrone or theelin. This hormone is found in urine 
and ia probably an excretion product formed from estra-
diol. 
3. Eetriol or theelol. .Another estrogen found ae an 
excretory product in urine. The.se three. substances all 
have similar but not identical properties. 
Estrogenio substances have a very wide distri~tion, 
not only in the animal kingdom but also in the realm of 
inanimate organic subeta.nc-es. It ie found in the ovary, 
in the blood, in the excreta of all of the vertebrates; 
in invertebrates end in plants; and in such organic sub-
st anoea as lignite, coal and petroleum. Zondek showed 
that the theotl, the granulosa cells and the corpus luteum 
all produce the follicular hormone. Chemically these 
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substances are closely related to the sterols, the male 
sex hormones and the carcinogenic hydrogenated phenan-
tbrene ring compounds, a subject we will comment on later. 
Since about 1930 voluminous literature has appeared on 
these hormones. The eetrogenic hormones were the first 
known of the ovarian hormones and were thought for a "-' 
time to be the sole hormone of menstruation. Consider-
able argument was rampant from 1926 to 1928 as to whether 
there was another hormone of menstruation. Doiey, et al 
(1929), obtained and publishei\ an article on follioulin 
from the urine of pregnant women. Crystalline estrone 
was isolated in 1929 by two men working independently 
of eac"'-' other. Doisy and Butenandt .obtained their pure 
crystals from the urine of pregnant wanen. Since then 
estrogenic substance has been isolated from mare's urine 
(Laqueur, 1930), from palm nuts (Butenandt and Jacobi, 
1933), from coal, petroleum and many other sources. Its 
chemical structure shows it to be basically like the 
phenanthrene ring group of compounds, namely morphine, 
the bile salts, ergosterol, vitamin n·, etc. This 
structure and its possible signifi ca.nee will be. consi4-
ered later in this paper. 
A well known faot of chemotherapy, that an alcohol 
is more active than a ketone, resulted in an attempt to 
reduce the keto group of the crystalline estrone to 
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produce a secondary alcohol. Schwenk and Hildebrandt 
accomplished this in 1933. They obtained the substance 
now known ae estradiol, the probable form in whioh the 
substance is first produced within the body. The intro-
duction of this alcohol group on the 17th carbon atom 
increased the potency of the crystalline eetrogenio 
substance about seven times. However, the effect of 
the product in the body was rather evanescent and so 
of a.o.mp.ra'tively little clinical value. For this 
res_son workers tried to make a more lasting but 
still potent substance. Butenandt accomplished this 
by conjugating the alcohol with benzoic acid to produce 
a benzoate of eetradiol whioh is absorbed much more 
slowly and whose effect is felt over a much longer 
period of time. This reduced the potency of the estra-
diol about one half but still it is much more potent 
t'*h the original eetrone. It is used quite •xt~ely 
in clinical work now and is known commercially as pro-
gynon-B. The introduction of still another alcohol 
group was suocei=sfully a.coompliehed but with 41.aa.ppoint-
ing results. This substance, estriol or theelol, with 
another OH group on the 16th ca.rbon atom is a rel ively · 
impotent estrogen and of little clinical value. 
In Kurzrok's recent book on the endocrines ( rzrok, 
1937) is listed rather canpletely the action of t estro-
• 
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genie hormone. Eight sepo,Ta.t e functions of estrone as 
determined from the administration of the crystalline 
ho rm.one are listed t hue: 
1. It stimulates the growth and development of the 
secondary sex characteristics of the female as well as 
the genital tract. This is beet demonstrated by the 
effect of estrone on the prepubertal individuals, in 
primary emenorrheas, and in the castrated individual. 
(Werner and Collier, 1933) 
2. The endometrium is stimulated to regenera.t.ion and 
hyperplasia. Thie occurs in the human during the 
postmenetrual phase of the norma.l menstrual cycle. 
It is in a sense only an estension of the first function 
we list here. (Jlari'ian and Parkes, 1930) 
3. Eetrone stimulates the growth of the mammary ducts. 
This seems to· be a. stimulation only to duotal growth in 
contrast to the action of the other ovarian hormone which 
stimulates lobular growth preparatory to lactation. The 
only apparent right to list this as. a separate function 
lies in the fact that the secondary sex characteristics 
are developed as prepubertal traits while this is cyclic 
in character after the onset of the menses, occurring 
each month of the menstrual epoch. (Kurzrok, Wilson and 
Cassidy, 1935). 
4. Estrone possesses a.n "ant 1mescul1ne" effect upon the 
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male genital system. In large doses the hormone inhibits 
both the primary and the secondary sex characteristics. 
That is, this hormone ie feminizing in action upon the 
male individual no matter if given before puberty or 
aft er. This is not permanent act ion. Aft er cessation 
of ad.ministration of the hormone, the testes again resume 
their funot ion. This effect of estrone is probably due 
to an inhibitory action on the hypophysis. (Spurrell and 
Ucko, 1938) 
5. Estrone has an effect on uterine motility (deni6d by 
some authorities, especially Kurzrok, et a.1_, 1936; Kurz-
rok, et a1, 1937) best illustrated during the menstrual 
cycle or during pregnancy wherei~ uterine contractions 
tend to occur when the content of eetrin is high and 
are absent or diminished when estrone is low in amount 
or when 1 t is neutralized by the action of corpus luteum 
hormone. A method of contraception was conceived on thd.s 
basis: Whitney and Burdick (1936) were able to show a 
definite slowing of the passage ova through the fallopian 
tubes following the administration.of eetrogenio substance 
into rabbits. Since the ova are quite short lived, it 
was thought that sufficient slowing in the paesa.ge of the 
ova would result in senescence and non-viability of the 
egg cell. This work hae not been proven as yet, however. 
(Reynolds and Friedman, 1930; Reynolds, 1931; and Bourne 
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and Burn, 1928) 
6. Banieohi showed in 1928 t h&t eatrone induces the 
formation of •pregnancy cells• in the anterior pituit-
ary body. (Kurzrok, 1937) 
7. Verzar and v. Arsay demonstrated in 1931 that estrone 
has a stimulating effect on the basal metabolic rate, 
causing it to increase ten to twenty percent in the 
castrated female rat. It has no demonstrable effect on 
the B.M.R. of normal males and females, however. (Xurz-
rok, 1~37) There is a possibility that the incret.eed 
B.M.R. is due to a stimulation of the thyroid gland 
following the stimuiation to the pituitary cells by 
the eetrone. 
The other ovarian menstrual hormone, the corpus lut-
eum hormone progesterone or progeatin, is produced.by 
the cells derived from the remaining tissues of the 
Gra.ffian follicle after its rupture at the time of ovul-
ation. Whether the lutein cell• are derived from tbe 
granulosa ctllle or from the theca interns. is a moo'tt 
question. The general consensus of opinion seems to 
feel that the granulosa cells ar.e the source of the 
corpora cells. The distribut iob of this hormone is , 
in contrast to the estrogeni c substa.noee, rather limit-
ed. It is produced normally ~Y the corpora only but 





The corpu.e luteum hormone was isolated by three 
groups of workers almost simultaneously in eeperate 
laboratories in 1934. They were Slotta, Ruschig and. 
Fels; Buten:andt; and Ylintersteiner and Allen (1934). 
Its structure was determined in 1934 by Butenandt 1 
et al, by converting two phy.eiologically inactive 
substances of known st·ructures into the active corpus 
luteum hormone. These were stigmasterol, a sterol 
obtained from soy beans, and pregnanediol, a saturated 
divalent alcohol occuring in the urine of pregnancy. 
(Allen, 1935), (Allen and Reynolds, 1935), (Allen, et 
al, 1935) 
The physiological action of the corpus luteum sub-
stance is listed by Kurzrok (1937) as five in number. 
Mackt (1938) limits it to only two signific-ant func-
tions for. this hormone. Reynolds and Allen (1933) de-
monstrated in the rabbit and Knaus in 1936 that balloon. 
recordings of uterine contractions showed definite in-
hibit ion under the influence of progesterone. This ha• 
been demonstrated to be an antagonistic action to the 
pitocin :traction of the posterior pituitary and to eetrin 
from the ovary. Mac~t also showed that progesterone 
•xerts an: inhibitory action on the· uterine endometrial 
hyperplasia produced by ~he eetrogenic substances. A 
number of investigators have demonstrated that this hor-
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mone is·an inhibitor of the estrous cycle and of ovula-
tion. 'Makepeace (1939) olaims that progestin inhibits 
the release of gonadotropio hormone from the pituitary. 
It is also a well known clinical fact that a corpus 
luteum cyst oauaes a patient to skip periods. The corp-
ora are the essential inhibitors of the cycle during 
pregnancy. (Hisaw, 1929) , (Hisaw, Fevol.d and Key er, 
1930) 
The anterior pituitary gland evolves a large number 
of hormones. The number of hormone• which this gland 
produces and their apparent regfllatory influenoes on 
all of the other glands of internal secretion have led 
many individuals to dub this bit of tissue, the •master 
gland". It -manufaotur es a hormone which influences the 
.. thyroid, one or more which regulate the ovaries, an 
ad.renal factor, a pancreatic hormone and apparently sev-
eral others. Those which are our concern are the gonad-
otropic, the thyrotropic and the adrenotropic principles. 
These latter two are of interest because the thyroid 
gland and the adrenal gland seem to influence the ovary 
in some manner, assumed by many authorities now to be a 
seoondary affect mediated by way of the pituitary gland 
aa a result of that glan<!e at.tempts to regulate the 
thyroid and the ad.renal glands. 
The substances produced by the anterior pituitary 
c 
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which influence the ovaries are known collectively 
as the gonadotropio hormones. The number of report• 
on these hormone• that have appeared in the past ten 
or twelve yea.rs 1• remarkable. '!'he first fundemental 
observations were those of Smith and Engle and of 
Aeoheim and Zondek in 1926, working separately. The 
hormones, probably proteins or closely associated to 
a protein molecule, have not been produced in a crys-
talline form as have the ovarian substances. Very 
similar hormone• have been found in the placents, in 
the urine of pregnancy, in castrate urine and in mare 
serum. These, since they can not be shown to be 
identical with the anterior pituitary substance, are 
oalled anterior pi'!tuitary-like substances (APL substances) 
or prolan. Perhaps the most distinctive diff•rence that 
can be pointed out between the APL substances and the 
true gonadotropic substance is that, though both seem 
to have about the same influence on the ovary in, the 
individual in whom the pituitary gland is intact, inl 
those whose pituitary is absent or inactive, the APL 
eubeta.noes are inactive or impotent. (Rose, 1937) 
' 
The gon&dotropio hormones are found in noc: other 
gland of internal secretion except the hypophysis. 
During pregnancy some investigators belie~tb.at there 
ie some other source of the gonadotropic hormones, 
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possibly the ohorionic villi. Zondek has made several. 
attempts to refute this conception. However, it is 
known that there is excreted during the pregnancy via 
the kidneys certain substances whioh are similar to 
but not identical with the anterior pituitary gonad-
otropio substances. Experimentally we find that these 
APL substances do not act on the ovaries of hypophysec-
tomized animals as will anterier pituitary extracts. 
Cole and Hart (1930) showed that the serum of pregnant 
mares during the midperiod of pregnancy contains large 
amounts of gonad stimulating substance which aote very 
similarly to the a. p. gonadotropic substances. Several 
oases are on record where the use of sera of pregnant 
women has been very effective where there seemed to be 
a diffioienoy of pituitary action (Hunt, 1938). 
. . 
It is generally accepted that the baeophile cell• 
are t......,e source of the gonadotropio hormones. Evans and 
his group (Evans, Korpi, Simpson, Pencha.rz, Wonder, 1936) 
separated by a prooe~s of salting out three distinct 
fractions of the gonadotropic group. These were an inter-
etial cell stimulating entity, a 1uteinizing fraction .. 
and a follicle atimulating part which prevents hypoplasia 
of this tissue and restores it after degeneration in 
hypophysectomized animals. ·'!'hie action is beat seen in 
the testes· where the cell• of L•ydig are regenerated in 
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a hypophyseotomized animal in contrast :to the near-
by oell• of the tubules which did not show response 
to thie fraotion. The same interst ial stimulation is 
seen in the ovary of these animals. The luteinizing 
fraction causes the formation of the lutein cells or the 
lute1n1zing of the walls of the !olliole but it is 
without effect on the interstial ·cells of the gland. 
The follicle stimulating fraction causes a growth of 
the follicles without repair of the interstitial cells 
(the so-called •deficiency cells") or luteinization. 
Upon the male this fraction causes regeneration of the 
tubules after degeneration but does not effeot the 
interstitial ·cells of ~be testes. 
It ·ia of inter•st to note the defference between 
the male and female hypophyses in view of their simil-
. 
arity of ~onadal influence. The anterior pituitary 
of the male secretes the same hormones as the female • 
. The difference lies in the fact that the female gland 
produces the gonadotropic- principle in a cyclic manner 
so that luteinization follows· follicle formation. In 
contrast the male gland produces a constant supply of 
these hormones to the gonads •. (Kurzrok, 1937). Pfeiffer 
(1936) showed t bl!Lt the same is true in the female wtth 
masoulinized hypophyses, a constant estrus is the re-
sult. 
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The thyroid gland and the thyrotropic hormone are 
of great interest to the gynecologist 1 i)ecause it has been 
demonstrated olini.oally that perhape the most readily 
available, the moat economio&l and the moat useful bio.;. 
logical of his emoorine armement arium has been thyroid 
eubatance or the thyroid hormone thyroxin. (Falk, 1937; 
Litzenberg, 1937) Though hormonal control of the pro.,;-
mction of the hormone thyro:xin is dependent upon the. 
pituitary gland through its produot ion of the regulating 
thyrotropic substance,. this gland has a powerful influ-
ence on the gonads. Thie is a secondary action mediat-
ed via the pituitary which emphasises again the central 
position of this·•master gland•. (Starr and Patton, 
1935) The thyrotropic hormone's re lat io~ to the thyroid 
is almost parallel to the gonad.otropic-gonadal relation. 
'l'his eimilari ty does not seem to be so strang.e when one 
considers that both hormones seem to be produced from 
the same type of cell if not from the same cell. The 
action of the hormone is to stimulate the thyroid to 
secrete thyroxin. Thia substance in turn is the regulator 
of the metabolism of the body; it is linked with the oxi-
dation processes of all of the body cells. 'l'he seleotive 
relationship of the thyroid to the gonads is due to the 
polyhedral nature of the pituitary basophile cells, a 
stimulu• to secrete thyrotropic substance may also be a 
-1.6-
stimulus to produce other tropic eubstanoes: gonad.otropic, 
adrenotropio,. etc. The intimate nature of thie relation-
ship ts suggested by Falk'• (1937) recommendation that a11 
menstrual disorders should be recommended for basal metab~ 
oli•m studies as a routine procedure~ Other men highly 
praise thyroid eEtracts as being very~effaoious as an 
ovarian stimulant even if the B.M.R. is normalfelightly 
inoreaeed. Care must be taken to avoid a thyroid reac.lt 
-tion or to precipitate a toxic thyroid state. (Litzen- . 
berg, 1937) 
Another closely -related gland which is of note is 
the adrenal glands. Here again we see s0mnhat of a 
rei'\;eration of•· the previous story,· eubstituti,ng the · 
adrenals ·for ·the thyroid g!t.and. The basophile cell• · 
again seem to be the elaborator ·of the adrenotrppio 
principle. lie know of two adrenal secretions and sus-
pect at least one more. or some mechanisms of· these two 
whioh we do not understand today. Th~ adrenals ~ay be 
dtvided into two distinct parts, the medulla and t~ 
cortex, the former produces the hormone epinephrin or 
adrenalin and the latter the cortical hormone cortin. 
Epinephrin is a simple amine compound related to tyro-
sine and the cort ioal hormone i• of unknown chemical 
structure.· '!'he a~ivity of epinephrin hae been eetab-
liehed to be at the myoneural junctions. of the eym-
.,, .. -_·, 
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pathetic nervous ey_etem. Ifl ••L Of special interest 
to u• is the fact that epinepheine causes contraction 
of the uterue during all phases ofthe menstrual cycle. 
The pregnant uterus also contracts under its influence. 
'!'he cortical "hormone seems to be the e.ubeta.nce of the 
ad.renal which is eeaent ial to life. It 1• the hormone 
used in Addison's disease or in individuals tn whom the 
adrenals have been removed at operation. Incidentally 
it is wo;rthy of note that only very •mall biita of ad-
. renal tissue needs be present to satiefy the require-
. ments of the body. Cortin may be used to prolong life 
almost ind-efin.itely in these cases in aontrast to ·the 
medullary hormone which is singultrly ineffective. 
Aside from theee two hormones we also find a. definite . 
inter-relationship between the gonads and the adrenals. 
Precocious puberty has been observed in both male and 
female in the presence Of a.n adrenal tumor or a hyper-
plasia. of the adrenal tissue. Other tumors give rise 
to masculiniZation of the female, the virilism syndrome. 
Addison's disease is frequently accompanied by a hypo-
lasia or atrophy of the ovaries. The mechanism· of 
these syndromes, however, is still obsaure and not well 
understood. 
The posterior pituitary has been shown to secrete· 




·a preseox and an ant i-diuret io principl.e. The latter 
two are usually combined as one in our pxesent prep-
arations on the market because of the methods of fract-
ionating. It is known as pitressin. The oxytoxic por-
t ion is called pitocin or o.xytocin. Thie fraction is· 
our concern in gynecology because it cause.s contraction 
of the uterus under certain conditions. Its activity 
is dependent upon at least four factors; the species of 
the animal, the phase of the menstrual cycle, whether 
the uterus is pregnant or not, and the etage of the 
gestation. Experiments are somewhat ooatradictory to 
a certain extent as to what occurs. Beyer&1 iti'.l'eetiga.t-
ors have shown that especially in rabbite, eetrin sens-
itizes the uterus to the action of pitocin while pro~ 
gesterone tends to render the uterus refractory to the 
action of this substance (Parkes, 1930). However, 
Kur.zrok, Wiesbader, Mulinoe and Wat eon (1938) made 
several studies of the action of pitreesin, estradiol, 
~nd progesterone by the use of the intra-uterine bag 
and on human subjects. Significant conclusions fran 
their studies are that the uterus shows spontaneou• 
contractions during all phases of the menstrual cycle; 
that the uterus reacts to pituitrin in a positive manner 
dUTing all phases of the cycle; progesterone produces 
uterine cramps during the poetmenetrual phase of the 
-< 
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oyole but not during th+>remenetrual p~aee; and that 
estradiol oocaeionalJ.y produces a rise in amplitude. r 
sad tonus and may produce cramps during the first half 
of the cycle without significant changes in the tracings 
from the inta-uterine balloon. It has been ahowm exp-
imentally and clinically that neither t.he hypophyeie, 
tbe ovaries or a live fetus is eesent ial to the onset 
and progress of lab.or. Thie suggests at least an add-
itional factor, possibly, as suggested by Kurzrok (1937), 
placental in origin. 
The phenomenum of menstruation is perhaps the gyn-
. ecologists chief concern for aberrations of this cycle 
are t be chief complaints of moat of bis patients. Long 
ago this ocouranoe of cyclic bleeding was thought to be 
a characteristic solely of the human being. For the 
major part of the last century it was believed to be 
a characteristic only.of the primates. Hartnan (1937) 
made more careful studies and showed that bleeding begina 
with the Selaohian fishes and occurs in the vertebrate 
scale upwards wherever the embryo developes within a 
!Jroo~ chamber at the e:xpenae of the parent. 
There is some debate among gynecologists as to just· 
what constitutes true menstruation. Some believe that 
menstruation is cyclic bleeding (Allen, 1935). Another 
school define it as bleeding only from a premenstrual 
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endometrium. (Kurzrok, 1937; Wieebader and Kurzrok, 1938; 
Ehrenfeet, 1937) This point is streseet\ in order to 
distinguish the normal. ovulatory oyole with bleeding 
from a premenstrual endometriuin from anovulatory sterile 
cyclic bleeding from a poetmenstrual endometrium •. The 
control ae ~:menst ~t ion seems to be almost entirely 
hormonal in obaracter. The hormones directly involved 
are the pituitary and the ovary. However, the influence 
of other glands is evidenced by the clinical observation 
that many of the menstrual dieordere are found in dye-
funct ions of the t cyro id, the adrenals , and the pancreas . 
The problem of the menstrual cycle is further complic'ated 
by the work of Teel and Cushing (1930) .!!!nd Hohlweg and 
Junkman in 1933 in which they tried to show that there 
probe.bly was a central nervous eyetem sex center, prob-
a~ly located 1n the floor of the third ventricle. Some 
work has been done to indicate the production of anti-
bodies or antihormonee in the body, antitheses of hor-
mones which act to balance hornonal action (Parkes and 
Rowlands, 1936; Werner, 1938). This work is not gen9 
erally accepted as yet. Some say the apparent anti-
hormones are in reality but the ~roduction of a refract-
oriness as a result of impurities in the extracts ueed. 
Crystalline prepaxations are aadd to fail to reproduce 
the antihormone phenomenum described by those using . 
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impure glandular ertraote. (Dusb&ne, et al, 1936) 
Aeide from theee factor• there ia also an auxillary 
mechanism present for the purpose of pregnancy and · 
delivery of the child at term. 
The normal menstrual cycle 1a generally conced-
ed. to be chiefly endocrine in nature. It is concern-
ed w1 th the development of the egg in the ovary , i te 
extrusion from-the ovary, ite transportation to the 
uterus and fertilization and pregnancy or subsequent 
nidation at the end of the cycle as a. part of the 
menstrual flow if fertilization does not occur. The 
rhythmical atimulue necessary for menstrual activity 
comee either· from Hohlweg and Junkman' • sex center, 
from the pituitary or from some gland evelving a 
"bleeding hormone• (Hartman and. Firor, 1937). Since 
the pituitary pj'pothesis is our most generally accepted 
one, we will use it as the starting point in the follow-
ing desoripticm of the normal menses. 
A rat her complete diagramat ic portrayal of the 
endocrine inter-relationship during the normal menstniial 
cycle was published in a paper by Kurzrok, Wilson and 
Cassidy (1935)~and is presented below sligthy modified 
for reference in this 41acuseion. Broken lines indicate· 
inhibitory action and solid lines stimulating action. 






























Both the follicle stimulating hormone and the 
luteinizing factor of the pitui*y gland are necess-
ary for a oomplet e cyel.e. and no•al menstruation. The 
hormones act in rotation.btitoverlap some at the mid-
point of the cyc1e or at about the time of ovulation. 
Considerable evidence points to a status of equilibrium 
between these two hormones at whbc.h time ovulation tends 
to occur (Lase, Smelser and KurzrQk, 1938). There 1• a 
quantitative relationship existing between theee two 
hormones, as well. (llarrian and Parkes, 1930; Kaufman, 
1938; Parkes, 1932; Szttrkacand Kurtz, 1938) If the 
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follicle stimulating hormone is present in an inad-
equate amount, an immature follicle which is incap-
able of normal luteinization results. Inadequate 
luteinization results in an inadequacy of the lut-
ein:' hormone and in consequence a postmenetrual rather 
than a premenatrual en4ometrium at the time of the 
meneee. Thie is the cyclic anovulatory sterile cycle 
which some authorities say is not a true menstruation 
. . . 
(Wieebader and Kurzrok, 1938). The other extreme, an 
. ~ 
excess of the luteinizing hormone. results ,Adue to· the 
continued action of the lutein princi~le on the endo-
metrium, in further stimulating the endometrium to 
hyperplasia of the glandular type and the inhibition 
of any bleeding. The corpus lut eum hormone renders 
the endometrium and the ovary refractory to the foll-
icle st~ulating hormone and so no new follicle devel-
opes and no second menstrual cycle begins. The balance 
between these two hormones is a rather delio&tely main~ 
ta.ined one. 
The course of the pituitary and ovarian activity 
during the cycle is a very precise one. The ovary, 
first under the stimulation of the follicle stimulating 
hormone of the anterior pituitary and later{&fter ovul-
ulation) under the influence of the corpus luteum frao-
. 
tion from the anterior pituitary forms first the follicle 
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and then the corpus luteum, ea.oh in turn producing 
their own hormones. Estrone, pro6uoed by the follicle, 
has a stimulating effect on the endometrium to· cause 
it to regenerate postme?letrually, an effect on the 
uterine musculature to render it susoeptable to the·ao-
tion of pitooin, and·upon the.mammary glands causing 
a growth of the duots of the gland. An inhibitory in-
fluence is also exerted on the pituitary (through the 
sex oenter?) whereby its presence in large ~mounts 
tends to restrict the product ion of· the gona.dotropio 
hormone. The aotion of eatrone is maintained through-
out the cycle to a greater or leaser degree since it 
ia pr-oduced t~oughout the oyole, after the rupture of 
the follicl.e.> by the corpus luteum. Its aot ion is 
neutralized some by the corpus lute~ hormone, however. 
The predominate hormone of the second half of the cycle 
is progesterone. Thie hormone stimulates the uterine 
glands to their secretory phase and renders the uterine 
musculature refractory to hormonal stimulation~ This 
hormone also stimulates the mammary lobules to prolif-
eration. The relative amounts of these two hormo~ea 
required to produce these changes in the oae1trated indiv-
idual has bee~ worked out by tcaufman in 1932 ( Kurs.rok, 
1937) to be 40,000 rat unite of eatrone and 35 to 50 
, 
rabbit uni ta of progesterone. ·These amounts have also 
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been checked by using them in the case of primary 
amenorrhea a.nd have been found to produce the de-
s ired results. (Kurzrok, Wilson and Cassidy, 1935) 
These amounts a.re not only sufficient to bring a.bout 
the menses themselves but also the full psychic and 
physica.l changes involved in a normal menstrual cycle 
a.a well. This amount is not adequ&te to bring about 
the development of all of the secondary sex charaot-
eristios, however. With but little doubtful evidence 
to sup·cort their claims, some invest igatore have 
hynothetitized a "bleeding hormone or factor" which 
causes cyclic flow. The source of this hormone is in 
di'lgreement. Some point to the ovary, others to the 
uterus and others to the pituitary. 
The ehdometrium at various stages of the cycle is 
characteristic. Under the influence of estrone we see 
a regeneration and hyperplasia, a simple growth of the 
epithelium from the bases of residual fundi of the 
glands lef"':; atler the nidation with the past menses. 
There is also an increase in the amount of submuoosa . 
as· well. Thie endometrium is the postmenstrual hyper-
plast ic type. The glands a.re typioally straight tub-
ules lined with ouboida.l epithelium and not showing 
secretory activity. Under the influence of progest-
. erone, the glands are stimulated to further growth and 
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to secretion·, becoming markedly tortuous and filled 
with secretion, the typical premenstrual endometrium. 
Near the end of the cycle, due to some· unknown st im-
ulus, the endometrium begins to slough and menstrua-
t 1on·1-ocmurs. An anovulatory cycle possesses only a 
poetmenstrual endometrium. at the time of the menses 
due to a laok of the progesterone et imulating phase 
of the cyole. 
'i'he effect of the_ sex hormones at various periods 
of the life cyole is a very interesting sidelight of 
the .. aotivity of the. hormones. Probably the earliest 
differentiating processes of ear1y cell: life, the 
motivating force is not endocrine in nature. The seg-
mentation and diferent iation proceed aooo~C11ng to some 
·foreordained pattern possibly due to some "germ plasm 
force", an l:lD:knOWn quality and quantity. The whole 
process is as regular and regimented as the ~ess 
parade of crack drill troops; beautifully precise through-
out. The developm·ent of the accessory sex organs, the 
uterus and the breasts most not eably, are apparently not 
on the .basis of endocrinology though they show a very 
early sensitivity to endocrine influence. It has been 
noted by a number of clinicians that the uterus is larger 
at birth than 1 t is shortly afterwards. The withdrawal 
of the influence of the maternally derived hormones may 
also bring about a single pseudomenstrual bleeding a week 
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or so after birth, the ao-called "non-menstrual genital 
hemorrhage of the newborn". The mammary activity of 
both sexes at birth and whUe at brea.et has been an ob-
aervat ion of long standing and a very good illustration 
of the sensitivity of the infantile tissues to the sex 
hormones. Thie aot ivi ty of the breasts. is moat pro- . 
nounoed during the· second week postpartum,. varying· in 
.quantity from a few deops to fifteen to twenty oubio 
centimeters. It is known more commonly as "witch:"• 
mil~". The pituitary hormone prolaot 1D. has· not been 
demonstrated in the infant but the APL substances and 
estrogenic substances are found in the urine and blood 
of infants during the first few days of life~ (Boule, 
1938) 
Little is known of the ·importance ·of the ovary dur-
ing the prepubertal years. We do lmow that the follicles 
mature to a oertain stage of deyelopment. and that at least 
some estrone is produced for a long time, even several 
years before the actual onset of puberty. This apparent-
ly parallels a s~il.ar awakening of the pituitary gonad-
otropic hormone activity in the baso'phUe cells of the 
an~erior pituitary gland. The various sex and secondary 
s.ex organs are selectively sensitive to the various hor-
mones. Thie is demonstrated by the ooouranoe of precoc-
ious puberty and menstruation in 9hildren with granulosa 
~ ..... -"' 
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cell carcinmna and vaginal epithelial hyperplasia like 
that of puberty following the therapeutic ad.ministration 
of the estrogenio eubstanoes in the treatment of infant-
ile gonorrheal vaginitis. (Lewis, 1933; TeLinde, 1938; 
Novak, 1938) Granulosa cell tumors are developed from 
rests of redundant· granulosa tissue left over in the 
early developnent of the oophorogenio apparatus of the 
ovary. In the same manner the arrhenoblaetoma, masou-
11niz 1ng tumors manifest themselves by their endocrine 
activity. They may develope from the persistent rem-
nants of the masculine scaffolding which precedes chron-
ologically the formation of the Mullerian apparatus. 
In oonolusion we .may say that, though the primary 
sex differentiation is due to the initial germ impulse, 
the prooees from there on out is due to endocrine aot iv-
1 ty. The gonad.a under the influence of the pituitary 
bear the chief ;burden of lµl.folding the secondary sex 
-
oharaoteristios as well as developing the genitals them-
selves. Though we know little quantitatively of the 
inter-play of these two - :aotors 1 the knowledge of their 
a~ivi ty has al:Lowed the gynecologists to explain more 
logica:Lly and physiologically the varying degrees of 
sexual reversal seen in hum.an beings and lower animals. 
This is in contrast to and a step above prior times when 
explanations were only on an anatomical basis which was 
-29-
applicable only to the well developed oases with marked 
structural changes~ Now· we can appreciate the less well 
developed cases of sexual reversals; appreciate that 
. . 
an individual with testes may be dormantly feminine and 
the contrary as well. On a purely endocrine basis we 
may now explain the viriliem syndrome of the adrenal 
cortex (androgenic. tissue·?); tumors of the pituitary, 
the so-called Cushing Syndrome; and tumors of the ovary, 
the arrenoblastomas. 
Little is ~own of th,repubertal funo1ion of the 
ovaries.· The basis of our knowledge is based for the 
most pe.rt on the negative ~videnoe furnished_ by castra-
tions. These oases are rather rare 1n the female in 
contrast to the male. The only effect noted in humans 
to date las been a failure of appearance of the menses 
together with a disproportionant skeletal growth like 
that seen in early ma1e castration that produces oµr 
•. lmUOh8. 
Long before the first menstruations , maturation of 
t be foll iolee and the product ion of estrone are noted 
by histological sections and hormonal determinations done 
on the blood. The usual sequence is f iret an incomplete 
maturation and then graduated degrees through partial to 
complete maturation without ovulation but possibly with 
periodic bleeding and finally full maturation with ovul-
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ation followed by formation 6f the oorpus luteum and 
. the beginning of the ovulatory type of monthly flow, 
the true menstrual period. There. is little doubt but 
what many girls ovul.ate with the first menses and some 
even before as adjudged from the reports of pregnancy 
immediately after the onset of the menses. or before the · 
first periodic flow in a f-ew oases. All evidence, how-
ever, points to this as an except ion rather than the 
rule. Biopsies of the endometrium of the uteri of gi%ls 
who are just beginn~~o have- a mont~ly flow show a- .post-
menstrual type rather\than premenstrual, indicating an 
anovulatory oyole with no format.ion of a corpus luteum-. 
·This indicates, as we stated previouly, the periodic 
bleeding which s.o many authorities do not wish to call 
true menstrual flow. The flow may be quite normal in 
amount· and regular in rhythum but more oft en there are 
irregularities of either the amount of flow or the time 
interva.l ... of the flow so that ol1n1oally these oases freq-
uently present themselves as instances of functional 
bleeding of mild or severe grade as the oase may be. 
Further evidence lies in the physiological sterility 
of most ohildbrides as those in India. Studies made in 
the Berlin Frau:anklinik by Mikilicz and Krausoh a few 
years ago on a large number of young primigravidae fran 
a standpoint of their cohabitational hfetory in relation 
., __ .. 
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to their feau.ndity show a eurpria1ng amount of steril-
ity for as long as several years in many cases in spite 
of an active. sex life from ~uberty. 
We. eee the same fundemental •tapering off 11 at the 
other end of the aex period of women_, the menopause. 
Here it has been demonstrated iY' endometrial biopsy a 
tendency to a hyper-estrinizat ion .due to failure of 
ovulation to occur. Functional hemorrhage, for thEtt 
matter, has been shown to occur at almost any age after 
puberty because an anovulatory cycle "is a rather freque 
ocourance through the lives of most women. 
ly unaccompanied by any abnormality of bleeding or othe 
symptoms so that the indi~idual is unaware of which cyc es 
are anovule.tory and which are not. It has been stated b 
some that the interval following an anovulatory cycle 
tends to be a long one in contrast to the anovulatory 
cycle which tends frequently to be shorter. Kurzrok, 
Lase, and Smelser (1937) noted in lactating individuals, 
too, a predominance of anovulatory cycles for a variable 
period of time. The record in several patients showed 
more than six successive anovulatory cycles in 1nd1v1due. s 
producing milk. Thia is said to hold true in from 55% to 
60% of the eyol.es during lactation. Such men as the abo 
three, Lahn and Riddle (1936), Dreel (1935), Kurzrok and 
Wilson (1936) and others have used this as a basis for 
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attempting to set up a physiological method of hormonal 
contraception. Their work is still .in the experimental 
stage; 
Though we believe that the endocrine mot 1vat ion for 
ovulation is probabl.y the pituitary,· the association 
with lactation also points to a possible inhibitory fact-
. . 
or in the eeoreti~g breast or, more remotely, an accel-
erating factor 1n the quiescent br.eaet. The ihhibitory 
factor was demonstrated experimentally in mice and rate 
by Dresl (l.935) and later confirmed by Riddle (1936). 
They showed tb.U prolaotin, the pituitary h_ormone et.im-
ulating lactation, is. c~pable of producing_ a tempo1'ary 
suppression of the ovarian cycle activity. Clinically 
we see three achoo.ls of thought as to the cause of fail-
ure of the follicle to perform as it usually does. Some 
treat these anovul.atory sterility and hyperestr1nization 
cases as being due to a lack of the follicle ripening 
factor (the anterior pitu•tary follioular hormone). 
Others consider the l.ute1niz1ng factor of the anterior 
pituitary to be the deciding endocrine. Hisaw and hie 
coworkers (1935) believe in a balance of these two fact-
ors. These investigators have, by varying the proportion 
of . these two gonad.otropic elements, been able to induce 
ovulation in non-ovul.ating· monkeys. The therapeutic value 
of t hie work is of. course suggestive onl.y because quant-
ities are not only species variable but also somewhat var-
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iable form one individual to another. The accepted 
therapy at the present time is the use of one or the 
other of the gonadotropic eubstancee· at or near the 
calculated time of ovulation with subsequent satis-
factory results shown by the presence of a premenstrual 
endometrium upon curettage. Some of these nsatisfaot-
ory" results may be false positives in that not all 
menstrual cycles in the same woman need be anovulatory 
and perhaps the cycle under teeatment was a normal " 
rather than abnormal oyole. (Novak, 1937) For a per-
iod of time near the time pf the menopause, the taper-
ing off of the gonads make such therapy a very variable 
quantity and of doubtful value. Some oases possess 
euffic•ent of the hormones that only a very small amount 
needs to be supplied artificially to produce the desired 
results. Other oases where the menopause is more ad-
vanced, larger doses are needed to ~roduce the same 
result and tide the patient over until an endocrine re-
adjustment has been made. 
The following discussion of gynecological problems 
·. 
from an endocrine standpoint wi-11 be on the basis of 
symptomatology; the cause .and treatment of the pat iente 
presenting symptom such as an amenorrhea, dysmenorrhea, 
menorrhagia, etc. Diagnosis and treatment are based on 
the bGe ic endocrine pattern heretofore outlined. 
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Perhaps the most common of the fema.le complaints 
in relation to the menstrual cycle with which the gyn-
ecologist muet deal ie the problem of amennorrhea. It 
may be defined as the absence of menstruat.ion either 
after the meneee have once begun (secondary amenorrhea) 
or a failure of the menses to 'tegin (primary· amenorrhea). 
The endocrine basis of menstruation limits this symptom 
to a malfunction of one of three glands or a combination 
of any of these. These glands are the ovary, the thyroid 
and the pituitary. (ll'rank, Goldberger, Salmone and Fel-
skin, .1937; Falk, 1937) 
The normal amenorrhea of the menopause and the pre-
pubertal .periods is most OPrtainly due to a l~ok of ovar-
ian activity. It is no doubt an expression oi the begin-
ning and the completion of the life span ~f that gland. 
Premature ovarian failure is essentially an early meno-
pause characterized by an amenorrhea, disappearance of 
eetrin in the blood and a persistence of the pituitary 
gonadotropic hormones. At times we also see concomitant 
vasomotor and subjective menopausal signs. Curettage 
reveals an atrophic uterine endometrium.· This amenorr-
hea is usually intractiable to treatment; one might say 
that it represents a short lived ovary. A possible 
relief especially in the young individual~ from the 
vasomotor and other subjective symptoms lies in ovarian 
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tran•plantation. Kurzrolt, Wilson and Cassidy (1935) in 
a study of primary and secondary amenorrhea treated with 
large doses of estrogenic eubatanoe, found eetrogenio 
substance to be most effective in secondary amenorrhea 
where they were able to bring about regular cyclical 
bleeding after the administration of aaseive doses of 
eetrogenio substance (up to 200 ,000 R.U .). Their study 
also confirmed Kaufman's findings that 40,000 R.U. of 
estrogen~o substance was neoessary to bring about all 
.. 
of the phenomena of the menstrual cycle., orga.nic and psych-
ic. In this group of primary amenorrhea we have the 
type which is without evidence of.pituitary.or thyroid 
disorder and in which the only clinical conclusion is 
that of 1J1pogonadal funot ion. Perhaps some of these are 
capable of normal activity if only the other associated 
endocrine stimulation were sufficient. That is, suffic-
ient pituitary st·imulation would result in ovarian act-
ivity. Primary amenorrhea of this type usually show a 
hypoplasia of the genitalia and an absence of or an under-
development of the secondary sex characteristics. Therapy 
in these oases is frequently of little ultimate therapeu-
t io gain. In some oases thyroid a4ministered will increase 
t be gpnadotropic secret ion to the t hreehold necessary fer 
ovarian activity. Cessation of leatment is usually fol-
lowed by a cessation of the bleeding and a regression of 
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the other characteriet ice that were brought about by 
the treatment. Since there is no· ultimate gain, and 
since it is not a life aa.v1Iig measure, many authorities 
do not consider such treatment worth while. Kurzrok 
(1937), however, believes that such treatment is desir-
able because it is a step in the right direction. That 
is , it is an attempt to restore the body to its normal 
state of functioning and it does make these patients 
more comfortable, perhaps more psychically than pb¥eically. 
Kurzrok apeaks hopefully of the possible preparation in 
the near future of more potent glandular preparations and 
preparations which will be absorbed slowly over a period 
of time. Thus, these patients would be much like our 
diabetioe at this time. The mild cases of hypogonadism 
of short duration are frequently permanently cured with 
the use of thyroid. (Litzenberg, 1937) 
That the pituitary may be the cause of an amenorr-
hea is readily demonstrated by the fact that Frolick's . . 
Syndrome (dystrophia adiposogenitalis} contains as a 
component an amenoerhea. However, not all pituitary amen-
orrhea are of this adipoeogenital dystrophic type. As a 
·rule, hypofunction of the pituitary gland does usually 
produce an amenorrhea, especially in those who have never 
menatruated. These primary amenorrheas most commonly show 
a concomitant growth d.isturba.nce of the skeletal system. 
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Since the pituitary is the whole driving force behind the 
genital tract, hypofunotion of this gland will manifest 
itself very frequently as varying degrees of genital in-
adequeoiee. There is usually an absence of the second-
. ary sex oharacteristios or at least a retardation; there 
is a pereistaBt absence of estrin in the urine because 
the pituitary is not stimulating the ovary to follicular 
formation; and there is a laok of or a diminished amount 
of gonadotropic principle excreted in the urine. Admin-
istration of estrone or of gonadotropio substance (not 
APL substances) to these patients will bring about temP-
orary relief but, like the completely nonfunctioning 
ovary, it is not permanent. (Kursrok, 1937} In oases ef 
seoondery amenorrhea attributable to_ pituitary hypofunc-
tion its response to therapeuees is mo~e promising than 
the complete types. In all cases of amenDrrhea, preg-
nancy or recent ar,ortion must be ruled out. Perhaps the 
Friedman test is the· clinician's most accurate laboratory 
method for this. Estrone, thyroid substance or the gonad-
otropic principle administered to these indi vidusJ.s freq-
uently Will stimulate the pituitary basophile cells to 
aot iv it y and, since the ovaries are normal, cyclic ova 
production will again be resumed. In the use of the APL 
substances and of the gonadotropic hormones, Roes (1937) 
deplores their indiecriminant use and advisee against it. 
It these substances are given, avoid the commonly made 
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error of not giving enough of these substanees. Roes 
blames many of the clinically poor results from these 
hormones to inadequate doaage. 
One of the usual component e of a hypothyroidism 
(myxedema) is an amenorrhea. This is no doubt due to . 
the ,fact th.at the thyroid gland is not secreting the 
I 
-
necessary amount of thyroid substance either because 
of a deficiency of thyrotropic principle from the ant-
erior pituitary or e. lack of response on the part of 
the thyroid to normal thyrotropic stimulation. The in-
adequacy of the thyroid is reflected via the baeophile 
cells of the adenopi tuitary as a hypofun~ion of the 
ovary, secondarily, and an amenorrhea. An apparent 
antithesis to this is seen in cases of hyperthyroidism. 
Here, too,. we frequently see an amenorrhea. This may 
be rationalized, however, when one considers the forces 
of compensation that we find 1n the human body. G~nerally 
speaking, small amounts of hormonal secretions injected 
into the individual are etimulat~g in nature while large 
amounts tend to act as substitutive sources and so depress 
the activity of the gland cells •. (Dacosta and Carlson, 
1933)' Whether this is a direct suppressive act·ion on the 
gland or not is not known. Rat her it is felt that it is 
probably a reflea control of the gland mediated via the 
"master gland", the pituitary. That is, as 1n hyperthy-
: 
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roidism, the large amounts of the hormone thyroxin pro-
duced tends to suppress the basophile cells of the pit~ 
uitary in an attempt to reduce the amount of thyrotropic 
principle formed and so reduce the activity of t ha thyroid. 
As the basophile cells slow down on the formation of the 
thyrotropic substance, the gonadotropic substances pro-
duced by the same sells is also dim1nlehed resulting in 
a deficient stimulus to the ovary and an apparent amen-
orrhea. Thie amenorrhea may be either of the primary or 
secondary type, usually the latter since most oases of 
hyperthyroidism occur postpuberte.lly. Treatment is of 
course along the lines of restoring the normal endocrine 
balance, reost easily done here by correcting the thyroid 
function. 'l'hyroid substance or thyroxin is used for hypo-
thyroid states. It must be remembered tha~ the hypothy-
roid state does not nefd to be a full blown myxedema and 
that it may not even show a significant change in the 
B.M.R. reading&. (Haines and Mussey, 1935) Hyperthyreid-
ism which does not yield to medical treatment of course 
comes under the surgeon's care for an extirpation of most 
of the gland. (Kurzrok, 1937; Falk, 1937) 
The etiology of dysmenorrhea, our next cons iderat ian, 
is ·aa id to lie in the development oi' the uterus (I eratl , 
1936). The development of the uterus in turn is under 
the control of the hormones and the central nervous sys-
tem. Additional factors are seen in the nervous makeup 
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of the individual and the const ~tutional type. The thin 
dynamic and "high strung" person seeme to be more prone 
to discomfort at the time of the menses. The emotional 
background is also seen as a factor in the frequently· 
seen too literal interpetation.of the t\e •sick period• 
by the woman. Young women are frequently taught t1Jat 
the period of menstrual flow is. a normal siok time for 
females ant that at that time she is supposed to be 111, 
weak, fatigued and very susceptible to all sorts of ail-
ments. 
Primary dysmenorrhea is our .concern from the view-
point of endocrinology bees.use almost all seconde.,ry 
dysmenorrheas, those that have their inception after 
the nomal onset of the menses, is on an anatomical 
basis and is seen most often following childbirth-trauma. 
Novak and Reynolds (1932) consider the cause of dyemen~ 
orrhea to lie in an imbalance in the estrin-progeaterone 
ratio; they believe that an increaee in theelin (eat;-in) 
and diminished amount of progesterone ie the cause of the 
pain. Moir (1934) carries their concept a step further. 
By a.ayetem otalloons in the uterine cav"ity, he profese-
ee to have shown that the sensation of gees.test discomfort 
coincided with the peak of a uterine contraction. Aleo 
each peak is marked by a disappearance of the uterine art-
erial· pulsat iona causing an area of iaohemia and pain much 
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like that that we see in angina peotorie and inter-
mittent olaudioation of a part. .Kennedy (1932) be-
lieves that dysmenorrhea is associated with degener-
ation in the Frankenhauser'a ganglion due to an estrin 
deficiency. Therapeutics in the latter concept is of 
course the administration of eetrin. In the first 
hypothesis, einoe the eetrin is believe to be in excess 
and the hormone present in diminished amounts is pro-
gesterone, this hormone is the logical therapeutic 
agent. B"oth of· ·these schools of thought are combined 
by those who stick to the middle path e.nd say it can 
be either or a little of both. These use whole ovar-
ian substance or the gonadotropic hormones from the 
pi.tui tar.y. gland. All .three schools claim about the 
same proportion of ouree or relief of the symptom. 
(Novak and :Riynolde, 1932; Novak, 1933; O&mpbell and 
His~ 1936; Elden and Wilson, 1936; Kotz and Parker, 
1937) Lachner, Krohn and Soskin (1937) have done an 
extensive study of :the problem of dysmenorrhea. Using 
an intrauterine bag, they claim to have shown tha.t 
estrogenio aubstan.ces augment uterine contract ions and 
progesterone inhibits. (Krohn, Lachner and Soekin, 1937) . . 
Kurzrok {1937) emphatically denies that this occurs and 
critioiaes these men's work on the baeie that the intra-
uterine bag stimulates the uterus to contract to a degree 
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tbat renders their conclusions inaccurate. However 1 
these ii.'ree workers have applied the endocrines in 
their oases, not by rule of the thumb but rather on the 
basis of tht!r physical findings with rather good 
therapeutic results. They divide their dyemenorrheic 
patients into two types. In the first are those who 
indicate the presence of an exeees of estrin by virtue 
of havi.ln15 a large well developed uterus with moderat~ 
to long contractions, as revealed upon bimanual pelvic 
examination and the intrauterine b,ag. These patients 
were relieved by the use of progesterone. In those 
individuals in which they found a small hypoplaetic 
uterus which shows little or no contraotility are treat-
ed with estrin with good results. It has been observed 
clinically for a lo rig time that pregnancy frequently has 
a salutatory effect on primary dysmenorrhea, probably 
because of the "shook• to the endocrines ae they a.djuet 
for the pregnancy and then readjust afterwards for tne 
nongravid state. 
The symptom of excessive bleeding, either at the 
usual t 1me of +the menses of between the periods may be 
due to an organic or. a functional ·condition. In the form-
er, the endocrines are of no avail as far as therapy is 
concerned for the conditon shows anatGmioal changes irrev-
ersable under the influence of any of the endocrinee. The 
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only part these substances play in the lesion is per-
haps prior to their development; an etiological factor 
which we will consider later •. Th'd functional type of 
bleeding frequently respond• to endocrine therapy be-
cause 1 t is usual~ due to an ovarian hypofunot1on, 
(Wilson and Kurzrok, 1936; Burch; et al, 1937). It hes 
been shown a number of times by various El.uthorit ies 
that the endometrium reflects proport ionatly the severity 
of the hypofunction cf the ovary. Therefore biopsy is 
indicated in these oases not only as an ind.ex of the de-, . 
gree of ovaian failure but also to differentiate.it from 
an organic lesion. 
"Menorrhagia or metrorrhagia may be seen ·at almost 
any age, In the adolescent irregular bleeding. is prob-
ably due to an endocrine immatur~ty.; a failure up to ·that 
time of the e~tablishraent of a normal endocrine balance. 
These·individuals almost inva.ria~ly correct themselves 
spontaneously but may need aid perhaps more peychologio-
ally than physically. These profuse bleedings of the ad-
olescent are usually caused by a hypertheelinism with a 
typical ·hyperplastic anovulatory endometrium. Admin-
istration of progesterone for a number of days, usually 
about five, prior to the time of the expected period will 
frequently peroipitate the o~ary back to its normal rhythm 
of fun·otion. Ohute (1936) makes the statement that an lhn-
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euffi ciency of the anterior pituitary is probablJ' the 
cause of most of the disorders of the other endocrines 
and may even lead to a secondary hypogonadism ~n the 
male and the female. Bur oh, et al ( 1937) have ltld 
rather good results with the use of progesterone in 
oases in which the ovaries have started activity. 
The middle age group is ~Y far the biggest clinical 
gr~p with the excessive gleeding syndrome (Falk, 1937). 
Perhaps the most striking form of functional menorrhag-
ia is the.t in which we find a glandular cystic endometrial 
hyperplasia, the so-called 11swies cheese" endometrium. 
Shroeder in 1912 wae·the first to emphaeime the correl-
ation between endometrial hyperplasia and the ovarian 
changes characterized by an absence of coiiora snd the 
presence of follicular. cyst e. It hl\e e inoe been demonf'o 
etrated experimentally that partial distruction of the 
ovary may cause an alternation in the estrous cycle so 
as to produce prolonged stages of estrus and glandular 
cyst io hyperplasia. of the endometrium. The same thing 
has been 'observed in partially hypophysectomized animals 
as well. Payne (1937) analyzed a series of 534 OS-see and 
attempted to dem0nstrate that a failure of correlation 
between endometrial hyperplasia an4 functional bleeding 
existed. ·Criticism of his paper by severa.J. men empha-
sized the lack of standardization of the term endometrial 
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hyperplasia. A loose application of the term bai led 
some workers to consider all growth of the endometrium, 
even that of the normal ovarian cycle, an edometrial 
hyperplasia. Burch, et a1 (1937) brought out that the 
evidence is almost conclusively a.n indictment of the 
hypofunctioning ovary as the immediate ca.use of the 
functional menorrhggia and metrorrhagia. The degree 
of hypoactivity is ··reflected alnJOSt ciuantita.tively in 
the uterine endometrium. cases <>f funct iona.l bleeding 
which show rathe+u11d symptoms and in which we can de-
onatrate a more or leae normal endomet:rium is indiative 
of a first degree ovarian failUJ9e; severe bleeding with 
a characteristic glandular cystic endometrium indicates 
a second degree hypo-ovarianism; and bleeding or· ,the 
opposite, an amenorrhea, ie found in cases with an 
atrophic endometrium as a reeul t of a third d~gree ( ocmp-
letel ovarian failure. 
In almost al1 cases of functional bleeding we see 
evidence of other endocrine dieturgance as well, no matter 
the degree of ovarian failure. The glands which are 
usually involved are the triad, thyroid, pituitary and 
ovary. The sum and substance of the whole matter is that 
metrorrhagia and menorrhagia are but manifestations of an 
ovarian hypofunction, which may be in itself primary l)r 
secondary to disease or dysfunction of the pituitary, the 
--
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thyroid, or to some constitutional disease affecting 
one or more of th4endocrine glands. The mioroeoopic 
examination of the endometrium ·is our yardstick of 
the severity of disturbance of the ovarian function. 
The principles of treatment as advocated by Kurz-
rok; Burch, .. et e.1; and others may be l~sted as four in 
number. First and foremost is a correct diagnosis. 
Then it is necessary that ~e treat that specific endo-
crine lesion. Beat results in the past h.ave been had 
with hypothyroidism, or with the administration of thy-
roid substance even where the B.M.R. is normal (Falk, 
1937; Litzenberg, 1937). The third car~inltl point is 
the eradication of any contributory factors ·of ill 
·health. The final resort is surgel)i Before using this 
means, one must be certain that the surgery elinlinatee ~ 
t'19 primary pathological condition if the patient .is to 
be au.red. 
··The consideration ofthe climaterio is an important 
one. This period marks the end of the sexual epoch in 
woman that was initiated at puberty. In fact, it is 
probably the refer•al of the process which we find mark-
ing the change from adolescence to sexual ma:lurity. KuTz-
roi: (1937) states that it eeeme to be a cessation of the 
pituitary-ovary~uterine relationship, The etiology is 
therefore dependent on one or a oomvination of tnese three 
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structures. Ultimately, of course there is always an 
ovarian failure. 
The menopause. is popularly conceived to be an abrupt 
process marked by an amenorrhea. This is an error. It 
is in reality a very gradual process beginning perhaps 
about the middle of ·or the latter part of the fourth 
decade of life as a slight diminution in the flow and 
perhaps without a conscious manifestation to the indiv-
idual. The whole process proceeds to the actual cess-
ation of the menses. Howe~rer, the number of oases On. 
record of pregnancy after the onset ct the menopausal 
amenorrhea indicates that the amenorrhea is no absolute 
criterion of ovarian inactivity. In short, the meno-
pause consists of an internal unconscious mechanism 
which is menifest ·somewhere in its course as an amenorr-
bea. Other presenting symptoms seen in varying degree• 
are neurovaecular symptoms, observed in almost all pa-
tients to a greater or lesser degree as hot flushes, 
sweats, palpitation, sleeplessness, nuilbness or tingling 
of the extremitiee and sensory neuroses especially of the 
throat; pelvic atrophies, perhaps most frequently an 
associated pruritue vulvae; and disturbances in other 
glands of internal secretion. About one third of the 
patients show weight increase of twenty pounds. or more. 
About 10% have joint symptoms. Languor and fatigue are 
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are common complaints. There is frequently a thyroid 
dysfunction at this time with a tendency to hyper-
rather thank hypothyroidal state, usually. Novak 
(1938) claims that the vasomotor symptoms are the only 
ones that can clearly be attributable '6o hormone f.lal-
adjustment. The other symptoms may possibly be pro-
duced secondarily as a resnlt of this imbalance. 
(Wiesbader and Kurzrok, 1938; Donald, 1938) 
When the en4oor ine glands are pi otured as a bal-
anced group, it is readily seen that the lose of one ~ .. 
of the group may upset the balance to a great er or ... 
lesser degree and necessitates a compensatory read-
justment of these glends to a new state of balance. 
Watson, Smith and Kurzrok. (1938) and Kurzrok and Smith 
(1938) seem to have demonstrated that the ovarian fail-
ure is due to inherent qualities· which. ·render the ovary 
refractory to the gonadotropio substance from tbe pit-
uitary. Thie lose of responsiveness is gradual in onset, 
culminating usually at about the forty-fifth year in a 
completely non-f1Jnotioning ovary. T!·is functional limit-
ation of the ovary has been demonstrated clinically to 
exist not only at this end of the sex epoch but also 
at the other end. Here, too, it is a graduated process 
of ovarian refractoriness progressing, however, frcm an 
insensitivity to the normally sensitive ovary of the 
menstrual oycle; the menopause in reverse, eo as to speak. 
-4~ 
The paint of least response to stimulation at this end 
of the cycle 11 at aboutthe age of six montha. Great-
est sensitivity to the gona.dotropio '3Ubsta.noes is eaid 
to be during the third decade of life. Merioard (1936} 
as a result of a number of att~pts to graft ovaries 
from young girls to elderly individuals with a large 
· number of failures to "take", believes that there must 
be some additional faotor. He suggests a general senile 
diathesis or perhaps a laok of adaptability in the more 
elderly individual. 
In about 85% of the women, the symptoms are not 
severe enough to force them to oonsult a physician. The 
symptoms of the biggest portion of the remaining 15% 
which are seen as patients by the profession are rather 
self limited and usually respond readily to some mild 
fom of therapy. Since the procese is one of ove.rian 
failure, the~qgical _course of therapy ie the administra-
tion of estrin or whole ovarian substance (Macleod, 1938}. 
Kurzrok (1937} recommends a combination of the two. He 
olaitns that the symptoms are usually relieved very prompt-· 
ly or are at least helped. Best results were seen in hle 
oases in those individuals who have a ocmplete menopause, 
ie. complete cessation of the menses. Pratt and Thomas 
(1937} bring out in their paper the marked psychogenic 
factor in this syndrome. In a series of ca.see whiOh they 
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considered well controlled, they reoieved almost an 
equally good result with ·a placebo as with the admin-
istration of the endocrines er sedation. Contemporary 
comment on their paper tended to indicate a majority 
of opinion that, though a marked psychogenic factor 
is probably present, better results are seen in those 
patients that recieve ovarian substance rather th8.n 
sedation or placebo, other things being equal. The 
administration of the hormones are only for· relief of . 
the distressing symptoms and a tapering off should ·be 
followed as much as possible. Novak_· (1938) in a· recent 
paper states that the results from estrogenio therapy 
for t be men~paueal symptoms are very variable,· rarely 
brilliant but usually satisfactory. 
The only tumors of the ovary which have endocrin-
ologi cal importance are but twa in number. Both of 
these are relatively uncommon but their chraoterietic 
endocrinologioal symptomatology justifies their being 
included here. Since these two tumors are best class-
ified by the character of the endocrine produot excreted, 
fhey are termed estrin producing .tumors and maeculiniz-
ing tumors or arrhenoblastomata (Novak and Long, 1S33; 
Novak and Gray, 1936). 
Arrhenoblaetomata (lovak, 1938) develope frOm un-
differentiated sex cells near the hilum of the ovary, 
·C 
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remnants of the\nale cell• which were present when the 
ovary was an undifferentiated gonad in the embryo. Thus, 
when these tumors suddenly begin to grow, they usually 
produce male oharact er 1st ice. That is , we have the ., 
viriliam syndrome: the breasts atrophy, the clitoris 
enlarges, and the hair distribution is of the masculine 
type. This is very interesting 1n vin of the fact 
tht.t, though androgenic preparations inhibit the anterior 
pituitary, estrin has a much greater inhibitory power 
and these tumors frequently develope in the face of 
both of these hormones. (Nelson and Gallagher, 1936; 
Wolfe and Hamilton, 1937) Thie syndrome (Falk, 1937; 
Varangot, 1938) is present in three types of tumors: 
arrhenoblast omata of the ovary, the. so-called Cushing 
syndrome desori~ed for tumors of the e.nterio& pituitary, 
and tumors of the adrenal cortex. The Cushing syndrome 
is the result of an overproduotlon of one of the pi tui-
tary hormones, probably adrenotropic whioh stimulates 
the androgenic tissue to inore<'eed activity and there-
by cause the masculinization of the individual. The 
aocompaning glyoosuria, obesity, etc. of the Cushing 
. syndrome is no doubt the reeult of involvement of the 
intra-mednlle.ry oonneot ion' or possibly to stimulation 
to production of other hormones by the pituitary. The 
male sex hormone that may be a.ct ive in the arrhenoblast-
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omata can arise from the tumor cells, from the·· medulla 
of the ovary which has potential masculinizing powers, 
or fo.,_..m a referred et imulation of androgenic tissue in 
the adrenals via the pituitary or perhaps even directly. 
It must be stated, however, that no one hae been able 
to demonstrate in thepresence of an arrenoblastoma an 
excess of the male sex hormone. Hormonal studies on 
these patients are of doubtful value since both the 
male and female hormones are commonly found in the urine 
of both sexes (Novak, 1938). Therapy is distruction of 
the tumor either by excision or with roentgen ray. 
The estrin produci~g ovarian tumors are either 
granulosa cell tumors or t heoa cell tu.more. The f iret 
is composed of typical granulosa cells while. the latter 
h&e a connective tissue-like or theo&-like character. 
Geist and Gaines (193 8) speak of the. presence of doubly · 
refractive fat in large amounts 1n these tumors as 
oha.raoteristic. Though pathologically differen~, these 
tumors are clinically identical because they both evolve 
the estrogenio hormones which are responsibae for the 
clinical picture. The granulosa type is by far the more 
common. These islands of embryonic cells may start to 
grow and function at any age, causing symptoms of hyper-
eetrinization. About ten percent are found 1n individuals 
before puberty, forty-two percent during aot ive eex life, 
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·and about forty-eight peroent poet-menopausal. The 
theoa .cell type is more prone to ocour after puberty 
and the menopauee t~n the true granulosa cell type, 
Falk. (1937). The origin of the stimulus to grow is 
not known, but it is generally cone idered to be of 
endocr1nolog1.oal origin, more probably the pituitary. 
Both of these tumors produce.large amounts of theelin 
(estr:lb) and clinically present a picture due to this 
hormone production. The symptoms are dependent some-
what on the age of the patient at the time that the 
tumor begins to function. In young girls, the second-
ary sex characteristics appear and the uterus enlargee-
a.nd they begin to menstruate. Tn the childbearing age 
the symptoms are masked by the normal menstrual aot ivity 
and the only evidence o:B an abnormality is an excessive 
menstrual· flow. The diagnoe is of a granuloea cell tumor 
during the active sex life of the individual is very 
frequently missed on this account. After the menopause, 
the symptoms are again the presence of anaooountable 
bleeding. Caro1nomatous degeneration of the uterus must 
be ruled out in all oases of bleeding. (Meeker and Loc&lio, 
1938) Removal ·O~ the tumors by eaoision or by roentgen 
ray· results in a prompt regression of the ser che.raoter ... 
istios developed as a result of the tumor. Thia ti.imor 
isA"rela ti ve benign ne6plasm~ though some. reports have 
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been made of malignant activity of thie type of growth. 
(Norris; 1938) 
One of the most startling and effaoious uses for one 
of the ovarian secretions ha.e been established during the 
past five or six years. That is the use of estrogenio 
preparations in the treatment or"aginitis, gonorrheal 
vaginitis in children and senile or infectious vaginitis 
of adults past the menopause. Lewie (1933) was the first 
to use estrogenio substances in the. treatment of vaginitis. 
He used the hormone on little girls having gonorrhe•l 
vaginitis with resulting startling changes in the epi-
thelium of the vagina, change in the character of the 
vaginal secretions and prompt alleviation of the condi-
tion. 
Gonorrheal va.gini tis is one c·f the most common 
affections of little girls, expecially during infancy 
and the first five years of life. Athough seldom ser-
ious, the disease is tedious and a source of great 
an,siety and unwarranted mort i:fication to the parents. 
It may also serve as a eouroe of secondary. infections, 
especially the eyes. It seems to be selflimited in 
character and seldom if ever leaves any permanent aftor 
eff eot e. Recovery is almost always complete before the 
age of puberty: the disease is seldom if ever carried '! 
over into the period of puberty. This condition is im-
portan~not because of any serious nature of the disease 
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but rather because of its high incidence in institutions 
where the increase in morbidity is significant. 
In 1933, Lewie publish~d his article which revolu-
t ioniz·ed the treatment of this condition. He conceived 
the idea that, since gonorrheal vaginitie is not seen 
after. puberty., the'~ infect ion must in some manner be 
altered by the changes that occur with puberty. It was 
common knowledge at that time tM the prepubertal vag-
inal mucosa is but four to ten cells in thickness 1n 
contrast to the pubertal vaginal lining which is twenty 
to thirty cells thick. Lewis, in his paper, credits 
Edgar Allen as the immediate stimulus for his idea for 
the treatment of this specific vaginitie. Allen had 
demonstrated in his laboratory that one of the ef.fects 
of estrogenic substances in the monkey wa.e an increase 
in the thickness of the vaginal mucosa from a few cells 
to many cells and a differentiation into two distinct 
zones after about 21 days. Lewie did not mention the 
work of Loeb and Kountz (1928} in which they recorded the 
results of experiments on guinea pigs with eetrogenic 
substances. Lewis and Weinstein (1938} reported several 
years later that the use of the estrogens in this therapy 
brought about a change in the pH of the vaginal tract from 
a neutral to strongly acid secretion like that seen in 




Before pubertl and after the cessation of activity . _ 
of the ovary, the fagina.J. mueoea is a delicate few· celled 
I 
mucous membrane wi~ h a neutral to faint.ly acid reaction. 
. I 
I 
During these years: it is an easy prey to invasion by 
! . 
pathogenic baoteri4, espeo.ial.ly the gonoooooi. This 
organism and other~ are unable to live in"a pH of less 
than 6. In patien~s treated with estrogenio substance 
I 
I 
the pH drops to 5 ~r less, appreaohing that seen during 
the normal aotivi tyf of the ovary in the female. On this 
I 
basis the treatmen~ of the senile and prepubertal types 
i 
of vaginitis ie f0'*1ded. 
Lewis (1933) ~ttempted to reproduce the findiBgs of 
Allen in ttie human b~ing. Hie report of e1iht oases treat-
ed with eetrogenio ~ubstanoe given hypodermioally 1n 
. I 
I 
I • . 
whioh six complete loures were obtained and two oases 
I 
I 
clinically oured bult returning later with an apparent 
! ,, 
reinfection rather ~han a reourrenoe of the previous 
infeotiOn 1s our fifst record of this type of ·treatment 
for gonorrheal vagthi tis in children. TeLinde and Brawn-
1 
er (1935) were the first workers to use suppositories 
I 
I 
rather than hypodetjnio injection of the eSJtrogen with 
I 
brilliant res'u1ts. I Pr8.tt and· Taomas (1937) found the 
I 
i 
suppositories to bei vastly superior to the hypodermic· 
injection of the su~eta.noe. TeLinde (1938) in a survey 
! 






hypodermic injeot ion effective in most oases but that 
looal application of the estrogen by means of suppos-
itorie.s to be the most universally effective of all 
methods. Treatment is 0011t inued ideally for si'x ·to eight 
weeks. The characteristic vaginal change is secured in 
11 to 15 day~ and smears are _almost invariably_ negative 
within an average of 17 to 19 days. Dosages are from 
50 to 100 rat units per day, twice to four times a week 
(Falk, 1938). TeLinde's series (1938) showed no case 
that' failed to respond to this therapy. Expense of the 
treatment is a dra:wback. It o'8ts as an avera.ge from et 
eight to ten do11a,rs for the necessary amount of estro-
genio eubetanoe. As a result .other methods -of treatment 
are being developed along other than en.d~orinologidll 
lines. 
Until even more recently the treatment of senile 
or postmenopausal vaginitis has been very ineffective. 
After cessation of the estrogenio influence of the ovary, 
the vaginal mucosa as depicted ab01te, reverts back to the 
thin structure of the prepuberta.l period of life. The 
seoretuibs are no longer acid and the mucosa becomes e 
easily infected. When infected, the patients complain 
of burni?lg, itching or pain in the vagina and coitus is 
practically impossible. Davis (1935) reported remarkable 
success in treating these cases with 81miotin (an estrog-
en) subcutaneously. In the majority of oases he ad.min-
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istered 100 rat unite of amniotin three times each week 
for about six weeks. S.ymptomatic relief was obtained 
within 10 days. Jaooby and Rabbiner confirmed De.vie' 
findings in 1S36. It bll.s been foilnd that vaginal supp-
ositories 1n this type· of vagini tis a.re not as satisfa()'I; 
t ory as the hypodermic administration. 
Another aide of the polygonal subject of the sex 
hormones has been their chemical structure and the olose 
similarity that· exists bc.,tween them and the sterols:, the 
male sex hormone and especially the carcinogenic hydro-
genated phenanthrene ring compounds. Since about 1930 
much literature has been published on these substances. 
Most progress is in. the isolation of the crystalline 
substance, discovery of their structural formulae and 
their synthetic product ion. 
The estrogenic hormone was the first known of the 
ovarian hormone• anci was thought for a time to be the 
eole horrrone of menstruation. Considerable .arguemen t 
wee rampant fran 1926 to 1928 as to whether there was 
another hormone of menstruat i04. The crystalline estrone 
was isolated in 1929. fr'lln the.urine -c;>f. pregna.nt,:ll:omen. 
Since then, estrone has been isolated from many sources, 
animal, plant and inanimate. Its chemical structure 
shows it to be basically like the phenanthrene ring 
group of 9ompmmds, namely morphine, the bile salts, 
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ergosterol, vitamine D, etc. 
\,\ .. 
group 
The corpus luteum hormone was discovered in 1934 
and. its chemical structure· worked out in the ea.me year 
by Butenandt. He derived his pure product from etig-
maeterol and pregna.nediol. His formula ie given here: 
Corpt.?.s luteum hormone 
. (progesterone) · 
.. 
Perhaps of more interest to the ge~eral profession 
at this time is not so muoh the exact whereabouts of the 
double b~ds or the pos11;1on of the keto- .or alcohol 
group but rather the similar! ty whioh we· see in the 
structural formulae of these hormones and the c1:lrc1no-
genic subetances of the·:tar series. Yamagiwa and Ich-
ikowa described the experimental production of cancer 
in rabbits with tar in 1915. Kennaway, Cook, Kager and 
others showed repeatedly that the oaroin·ogenic compounds 
contained a hydrogenated phenanthrene ring. (Novak, 1937) 
-59-
The presence of this ring in both these carcinogenic 
substances a.nd the eetrogenic substances; the fact that 
certain members of the coal tar series have been definit-
ely established as being estrogenic; the extensive pro-
liferation of the endometrium during the postmen8trual 
phase under the influence of eetrin, a process so comp-
arable to carcin()Jja in· rapidity and extent of growth; 
certain experiments which seem to indicate a probability 
t bat est rogenic substances may, under certain conditbons 
become carcinogenic; all lend credulity to the idea th~t 
the estrogens are possibly potentially oarcinogenic. 
Novak and Yui, in an article on endom.etrial hyper-
plaeiae (1936) , cone idered t hie point fairly thoroughly. 
Novak (1937) in an article a year later again emphasized 
the close correlation of structure. He comments on the 
frequency in which eetrin is fpund in the urine of women 
long after the menopause and even after surgical castra-
tion. His conclusion that, since the placenta will dur-
ing pregnancy produce large amo1.mte of eetrin, other org-
ans could do likewise. One must remember, however, the 
origin of the eetrin producing port ion of the placenta 
may be the residual granuloea cells that accomp~ny ·the 
ovum to the uterus where it implants, a factor not pres-
ent in any of the other organs in the body. Novak and 




endometrium and 104 oases of adenocarcinoma of the 
fundus of the uterus, correlated what seemed to be 
sµffioient evidence for Novak (1937) to state that, 
•the inference would. seem justified then that a 
poetmenstrual endom.etrium suf jected to a ·persistent 
eetrogenio stimulation 1 s predisposed to carcinoma.• 
In the breast, repeated injections of estrin have 
apparently produced cancer in a surprising number of 
laboratory animals and, once started the malignant 
process continues even after the hormone is withdrawn. 
A cancer-like picture has been produced in the cervices 
of mice by Perry (1936) and Loeb, et al (1936) using 
eetrogenio substance•. 
In direct contrast, Roberts (1S36) stressed the 
faotor of heredity rather than the sex hormones in the 
etioaogy of cancer. He tends to mil:iimizes the r~le of 
the hormones 1n the cause of cancer. Macklin a number 
of year~ ago (1933) analyzed a number of oases of ento-
dermal tumors and found that such tumors were twice as 
oom.1Don 'in the male as in the female. She grudgingly 
admits the possibility of the sex hormones being a fact-
or but tends to depreciate the likelihood. She feels 
that heredity plays a much greater role. She says, •the 
explanation of this increased incidence 1n the male 
appears to rest up9n factors inherent in the male con-
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etitution; factors which are genetic (sex linked) in 
their basis and not merely dependent upon hormonal 
infltences arising from male gon~al tissue." 
None-the-less, this close chemical relationship 
admits- th• possilJility of the ;formation d oarcinogen-
ous substances from the sterol compounds by eome ab-
normality of _metabolism. Cook (1933) pointed out that 
such a transformation would involve only reduction, 
dehydration and dehydrogenation, processes whdch read-
ily oaour in the animal body normally. This is indeed 
a very promising lead for those in cancer research. 
Many a.re now working on such phases of the cancer issue 
at this time and it ie not improbable that new develop-
ments may be forthcoming soon either in refutation or 
support of · the t heo ;r. 
SUMMARY 
1. The endocrine system is normally in a state of hlper-
feat balance, the control of which seems to center for 
the most part_ in the ~"nte.rior pituitary gland. There 
may be a central nervous system control, however. 
2. Estrone is the ovarian hormone of the first 1-lf of 
the cycle and progesterone of the last half of the men-
et rual ay ole-. 
·3. The va.r~oua trop:io ·se·cr~t ions· of the adenopituita.ry 
are very closely related and may be produced from t_be 
-ea.;; 
same cell (be.eophile). 
4. Indioe.t 1one for the use of estrone and pro.gesterone 
during the menstrual cyele are rather definite. 'The 
amounts required to produce all of the phenomeaa1..of the 
menatrual cycle has also been worked out. 
5. Substitutive therapy, though expenaive and nonaurative, 
is a step in the right direction· especially for young 
individuals in that it rehabilitates the individual not· 
only physically but mentally; it makes their lives more 
comfortable and liveable thereby. 
6. Generally speaking, large doses of the endocrines tend 
to depress that gland while small doses are stimulating. 
Thie may be due to a direct effect, and effect mediated 
through the pituitary gland, or to the formation of anti-
hormonee. 
7. In considering the/cause of any malfunction of menstru-
ation, we must consider at least tbree glands, the ovary, 
. the adenopituitary and the thyroid gland. 
8. Primary amenorrhea and the menopause are -essentially 
express ions of the same disturbance, a hypo-ovarianism. 
The ovarian aot.ivity in the amenorrhea may be due seoond-
e.rUy to pituitary or thyroid pathology or it may be like 
tht of the menopause, an ovarian failure or hypofunotion. 
9. Whole ovarian substance and the estrogens are our most 
effacious treatmentror alleviation of the menopausal eymp-
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toms. 
10. J)ySmJJnorrhea of funot ional nature may be due to 
either a hyper-eetrinization or to too muoh progest-
erone. Treatment is an effort to supply the necess-
ary annagonist to buffer the \iormone that is present 
in exoees. 
ll. Excessive bleeding must be correctly diagnosed, 
most preferably by biopsy. A careful esamination of 
the endocrine system is eseentlial, espedi_ally the 
thyroid and the ovary. Treatment depends upon the 
cause of the symptom. 
12. Arrhenoblaetomata (me.sculinizing tumors) and granu-
loee. cell tumors (estrin producing tumors) are the only 
two ovarian tumors of endocrinological importance. Treat-
ment for both is surgical. or irradiation. 
CONCLUSIONS 
l. The subject of endocrinology is a young one which is 
st ill ppen t.o mueh investigation and revision before 
we can expeot stability. 
2 •• Glande of internal secretion may refleot their abncr"ral 
function by influencing the pituitary's control Of some 
other gland. 
3. It must be remembered that the endocrine system is ,an 
imperf eotly balanced set of glands. Deviations in one 
(""\ 
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gland may ma:nif est itself frequently as upsets in the 
endocrine balance rather than ust too much or too little 
of that one glandular secretion. 
4. Thyroid substance or thyroxin ie our cheapest, most 
available and most generally eff aciou.a endocrine prod-
uct. 
5. The treatment of menstrual aberrations should be on 
the basis of etiological factors. 
6. The carcinogenic relat ionahip of the ovarian hormones 
ie an unsolved problem so far. Evidence so far seems 
to indicate a probable indictment of the sex hormones._ . _ 
7. The past two decades have seen discoveries in the field 
of endocrinology which have been startling 1n th~ir scope 
and kaleidoscopic in their rapidity, All has not been 
said about these substances. We can expect more discov-
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